Fig 1: ScFv 46.1 transports neurotensin into the MnPO. (A) Cartoon of the antibody-NT construct. (B) Purified fusion constructs resolved with SDS-PAGE and Coomassie staining. (C) Conjugation of neurotensin to the parent antibody (lower image) has no influence on the binding- and internalization activity of 46.1-scFv-Fc-LL-NT (upper image) in iPSC-BMEC-like cells, as evident from both antibodies having a characteristic punctate appearance on the plasma membrane (pseudocolored in red) and localization to the internal cell–cell contacts (pseudocolored in green). Scale bar, 20 µm. (D) NT alone or antibody-NT-fusions (control and 46.1 antibody) were added in serial dilutions to NTSR1 (G-protein coupled receptor (GPCR)) expressing CHO-cells. The activation of NTSR1 was measured as a chemiluminescent light, produced by active β-galactosidase, which formed upon the recruitment of β-arrestin to the NTSR1 construct. The inset provides the fitted EC50 values (mean ± s.e.m.). The curves represent one biological replicate and n is listed in the inset. One-way ANOVA was used to analyze the data. The EC50 value for 46.1 fusion differs significantly from the EC50 of neurotensin with a Holm corrected p-value = 0.009 (Table A1). (E) Mice were injected at time 0 via the retro-orbital sinus with the control and 46.1 fusions or free neurotensin and the temperature recorded with an intraperitoneally-implanted probe, as described in the Materials and Methods Section. Mixed ANOVA was used to model the data (mean ± s.e.m.). The Holm–Bonferroni post hoc multiple comparisons test revealed a statistically significant difference between the 46.1-scFv-Fc-LL-NT group vs. the control (p = 0.001) and NT (p < 0.05) (Table A2).
Supplier Page from DiscoverX for PathHunter® eXpress NTSR1 CHO-K1 β-Arrestin GPCR Assay